Marks & Spencer has launched a new range of 'nutrient-dense' foods, specifically targeting individuals who are on weight-loss injections. The retailer claims these products will satisfy customers who are eating less due to their use of GLP-1 medications. The range, launching on January 5th, includes salads, breads, yogurt bowls, and chicken dinners, all perfectly portioned to contain high amounts of nutrients per calorie. This move comes as people across the UK increasingly turn to weight-loss jabs like Wegovy, Zepbound, and Saxenda to suppress their appetites. However, the trend poses new challenges for food retailers like M&S, which must maintain sales as some customers eat less. Annette Peters, the head of food innovation at M&S, emphasizes the importance of these nutrient-dense products for those reducing their food intake. The company's efforts to target the weight-loss jab market are not isolated; Morrisons has also partnered with Applied Nutrition to offer 'GLP-1 friendly ready meals'. This development could intensify pressure on food retailers if pharmaceutical companies successfully bring an anti-obesity pill to market. While weight-loss jabs have gained popularity, they remain expensive for most users. Pharmaceuticals are racing to develop weight-loss pills, which would be easier to store, distribute, and administer, and potentially cheaper than injections. However, questions persist about the side effects of GLP-1 medicines, which are also used to treat diabetes, including pancreas-related issues that have prompted further research into their side
